Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding SOPHiA GENETICS SA changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of SOPH: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3240+8
Shares16.5M17.7M+1.19M (+7.2%)
Value$51.2M$84.3M+$33.1M (+64.6%)

New holders (11)

Institutions that held SOPHiA GENETICS SA at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to SOPH in Q3 2025
InstitutionSharesValue% of portfolio
Alta Wealth Advisors LLC1,409,160$6.71M2.40%
FNY Investment Advisers, LLC44,705$212.0K0.07%
Thompson Siegel & Walmsley LLC29,780$142.0K0.00%
Susquehanna International Group, LLP18,479$88.0K0.00%
Gsa Capital Partners LLP12,454$59.0K0.00%
Squarepoint Ops LLC10,231$48.7K0.00%
Savvy Advisors, Inc.10,000$47.6K0.00%
Simplex Trading, LLC1,026$4.00K0.00%
Tower Research Capital LLC (TRC)491$2.34K0.00%
Groupe la Francaise120$5690.00%
SBI Securities Co., Ltd.1$50.00%

Sold out (3)

Institutions that held SOPHiA GENETICS SA at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of SOPH in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Ridgewood Investments LLC34,449$106.8K
Citigroup Inc1,389$4.31K
JPMorgan Chase & Co198$614